Ambrichor

📍 Győr, Hungary🗓 Founded 2018👥 5 employees💰 Last funded Jun 2019
Biotechnology Research🌐 ambrichor.com
Website LinkedIn
Ambrichor provides access to biological samples for the development and regulatory validation of blood-based cancer tests. Ambrichor collects plasma samples from a high risk, asymptomatic cohort of individuals and cancer patients. Our first indication is lung cancer, in which our region has the highest incidence worldwide. The sample collection fulfils the most rigorous pre-analytical requirements of cell free nucleic acid, exosome or epitope analysis. It also fulfils the regulatory, quality control and documentation requirements of clinical validation for registration studies submitted to Notified Bodies or US Food and Drug Administration.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2018
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Spain
1
Frequently asked questions
Who invested in Ambrichor?
Ambrichor has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Ambrichor last raise funding?
The most recent investment in Ambrichor recorded on gritt.io was in June 2019.
When was Ambrichor founded?
Ambrichor was founded in 2018.
What industry is Ambrichor in?
Ambrichor operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Ambrichor based?
Ambrichor is headquartered in Győr, Hungary.